Literature DB >> 21715705

Late-onset lower motor neuronopathy: a new autosomal dominant disorder.

M Jokela1, S Penttilä, S Huovinen, P Hackman, A M Saukkonen, J Toivanen, B Udd.   

Abstract

OBJECTIVE: Characterization of a new type of late-onset autosomal dominant lower motor neuron disease.
METHODS: Patients from 2 families underwent detailed neurologic, electrophysiologic, muscle biopsy, and laboratory investigations. MRI of lower limbs was performed in selected patients. DNA samples from leukocytes were used for molecular genetic linkage studies.
RESULTS: First symptoms were muscle cramps and fasciculations after age 25-30, followed by a slowly progressive proximal and distal weakness without overt atrophy during the first decades of symptoms. Nerve conduction velocities were within normal range and EMG showed widespread neurogenic alterations. Muscle biopsy revealed characteristic neurogenic findings: fiber type grouping and group atrophy. MRI showed diffuse fatty-degenerative changes, marked in medial gastrocnemius.
CONCLUSION: Exactly the same clinical phenotype has not previously been described, and linkage studies showed exclusion of known chromosomal loci for hereditary motor neuropathies, suggesting the disease we report may represent a new disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21715705     DOI: 10.1212/WNL.0b013e3182267b71

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2.

Authors:  Sini Penttilä; Manu Jokela; Peter Hackman; Anna Maija Saukkonen; Jari Toivanen; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

Review 2.  Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.

Authors:  Manu E Jokela; Bjarne Udd
Journal:  J Mol Neurosci       Date:  2015-11-16       Impact factor: 3.444

3.  Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centers.

Authors:  Mazen M Dimachkie; Iryna M Muzyka; Jonathan S Katz; Carlayne Jackson; Yunxia Wang; April L McVey; Arthur Dick; Mamatha Pasnoor; M Tahseen Mozaffar; Z Xiao-Song; John T Kissel; E Ensrud; Jeffrey Rosenfeld; Richard J Barohn
Journal:  J Clin Neuromuscul Dis       Date:  2013-09

4.  Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy.

Authors:  Julius Järvilehto; Sandra Harjuhaahto; Edouard Palu; Mari Auranen; Jouni Kvist; Henrik Zetterberg; Johanna Koskivuori; Marko Lehtonen; Anna Maija Saukkonen; Manu Jokela; Emil Ylikallio; Henna Tyynismaa
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

Review 5.  Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.

Authors:  Kristien Peeters; Teodora Chamova; Albena Jordanova
Journal:  Brain       Date:  2014-06-25       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.